1.Role of different phenotype tumor-associated macrophages in tumor progression
Haoyue GUO ; Rui MAO ; Ran WANG ; Erjia ZHU ; Donglai CHEN
Chinese Journal of Clinical Oncology 2018;45(9):482-486
Innate immune cells are highly represented in the tumor microenvironment,and among the most abundant of these are macrophages.However,macrophages are broadly categorized as"classically activated"pro-inflammatory M1 macrophages and"alter-natively activated"anti-inflammatory M2 macrophages,which might be too simplified to describe the various phenotypes and func-tions of tumor-associated macrophages(TAMs).Most TAMs are now reclassified into CD68+TAM,CD163+TAM,CD204+TAM,CD169+TAM,and CCL18+TAM,among others,according to the different expression of surface proteins.These surface proteins have different types of ligands and regulate different signaling pathways and cytokines.Therefore,even if these subtypes of TAMs have similar ef-fects of promoting or inhibiting tumors,the mechanisms involved and the induced clinical manifestations are different.In this paper, the effects of various phenotypes of TAMs on tumor growth,metastasis,prognosis,and clinical relevance are reviewed.
2.Advances in the accuracy of the frozen section (FS) identification for early-stage lung adenocarcinoma
Xiaofan WANG ; Donglai CHEN ; Erjia ZHU ; Chang CHEN ; Yongsheng ZHANG ; Yongbing CHEN
Chinese Journal of Thoracic and Cardiovascular Surgery 2020;36(2):125-128
The frozen section (FS) technology has been widely used in the process of surgical pathology since its time-saving nature exhibited superiority over traditional paraffin method. Therefore FS, of great value in providing preliminary pathological diagnosis, offers guidance in the extension of surgical resection. However, it remains controversial whether the early-stage lung adenocarcinoma could be accurately identified in FS. This review aims to generalize the studies concerning the accuracy of FS in identifying early-stage lung adenocarcinoma, analyzing the interference factors, comparing the similarities and differences between frozen sections and traditional paraffin sections. It also gives insight into whether FS can provide significant guidance for surgeons to perform resection on early-stage lung adenocarcinoma.
3.Recent progress of lymph nodes management of clinical stage ⅠA lung cancer
CHEN Donglai ; REN Yijiu ; ZHU Erjia ; SU Hang ; CHEN Chang
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2018;25(10):890-894
Systematic lymph nodes dissection has been a standard procedure in lung cancer surgery, while the manipulation of mediastinal lymph nodes for early stage lung cancer remains controversial since surgeons have been weighing the advantages and disadvantages of different methods of lymph node dissection. With an increasing in early stage non-small cell lung cancer patients in recent years, there are more and more intensive studies especially focusing on the mediastinal lymph nodes dissection of clinical stage ⅠA lung cancer. In this review, the lymph nodes management of clinical stage ⅠA non-small cell lung cancer, especially systematic lymph nodes dissection and sampling as well as lobespecific lymph node dissection, are summarized.